MRGPRX4 antagonist(Guangzhou Boji Medical & Biotechnological)

N/A

Report date: 2025/03/20 15:01:40
NME

Base Information

Drug NameMRGPRX4 antagonist(Guangzhou Boji Medical & Biotechnological)
Drug Alias NameMas-related G-protein receptor X4 antagonist (Guangzhou Boji Medical & Biotechnological)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMas-related G-protein coupled receptor member X4 antagonists
TargetsMas-related G-protein coupled receptor member X4
Therapy Area/IndicationsPruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBoji Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoji Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPruritus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A